NVDA Q3 Earnings Alert: Why our AI stock picker is still holding Nvidia stockRead More

Flora Growth to launch cannabis grow kits in Germany

EditorEmilio Ghigini
Published 03/25/2024, 09:31 AM
© Reuters.
FLGC
-

FORT LAUDERDALE - Flora Growth Corp. (NASDAQ: FLGC), a global cannabis consumer-packaged-goods company, announced plans to release a cannabis home grow kit in Germany, aligning with the country's new recreational cannabis legalization law. The law, effective April 1, 2024, permits adults over 18 to possess up to 50 grams of cannabis for private use and to cultivate up to three plants.

The company, with a presence in Germany through its wholly-owned subsidiaries since 2017, is positioning itself to capitalize on the anticipated legalization surge. Flora Growth holds a significant seedbank, claiming to be one of the largest globally, with over 200 strains, including several award-winning varieties.

This resource is expected to play a crucial role in Flora's strategy to meet the demand for home cultivation in Germany, a market the company estimates could reach $400 million post-legalization.

With the German recreational cannabis market's potential pegged at $4.2 billion and the broader European market forecasted to hit revenues of $10.2 billion, Flora Growth is eyeing a substantial opportunity. The company's experience in Germany, having secured the first medical cannabis license and sold the country's first gram of medical cannabis, provides it with an established foothold.

Starting July 1, 2024, German adults will also be allowed to join nonprofit social clubs, with a cap of 500 members each, where they can purchase up to 25 grams per day or 50 grams per month. Flora intends to supply these clubs with seeds and cuttings for startup material.

The company draws parallels with the Canadian market, where nearly one in ten cannabis consumers reported home cultivation following legalization. Flora's CEO, Clifford Starke, expressed confidence in a similar uptake in Germany, stating, "We believe German adults will exhibit a similar pattern and we intend to give them the tools to do."

The cannabis home grow kits, select genetics, and cuttings are slated to be available on a limited quantity basis for personal use in the German market through justcbdstore.de and preferred partners.

This initiative is based on a press release statement from Flora Growth Corp. and reflects the company's efforts to adapt to and capitalize on evolving cannabis legislation in Germany.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.